Specify a stock or a cryptocurrency in the search bar to get a summary
Anatara Lifesciences Ltd
ANRAnatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. The company offers Gastrointestinal ReProgramming, a proprietary formulation to address irritable bowel syndrome. It also provides Detach for the treatment of diarrhea disease in piglets. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia. Address: 81 Flinders Street, Adelaide, SA, Australia, 5000
Analytics
WallStreet Target Price
2.63 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ANR
Dividend Analytics ANR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ANR
Stock Valuation ANR
Financials ANR
Results | 2019 | Dynamics |